Region:Asia
Author(s):Rebecca
Product Code:KRAE0872
Pages:83
Published On:December 2025

By Type:The market is segmented into various types of ventricular assist devices, including Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Biventricular Assist Devices (BiVAD), and others. Among these, LVADs are the most widely used due to their effectiveness in treating advanced heart failure. The increasing incidence of heart diseases and the growing preference for minimally invasive procedures are driving the demand for LVADs, making them a dominant force in the market.

By End-User:The end-user segmentation includes hospitals, cardiac centers, home care settings, and others. Hospitals are the primary end-users of ventricular assist devices, as they are equipped with the necessary infrastructure and expertise to manage complex cardiac cases. The increasing number of cardiac surgeries and the need for advanced treatment options in hospitals are driving the demand for these devices, solidifying their position as the leading end-user segment.

The Vietnam Ventricular Assist Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic, Abbott Laboratories, Boston Scientific, Terumo Corporation, SynCardia Systems, Jarvik Heart, ReliantHeart, HeartWare International, LivaNova, Getinge Group, Abiomed, Xvivo Perfusion, AtriCure, CorWave, EBR Systems contribute to innovation, geographic expansion, and service delivery in this space.
The Vietnam Ventricular Assist Devices market is poised for significant growth as healthcare infrastructure continues to improve and the prevalence of heart diseases escalates. With the government focusing on enhancing healthcare access and quality, the integration of advanced technologies will likely lead to better patient outcomes. Additionally, the increasing collaboration between local and international firms will foster innovation, ensuring that VADs become more accessible and effective in treating heart conditions in the Vietnamese population.
| Segment | Sub-Segments |
|---|---|
| By Type | Left Ventricular Assist Devices (LVAD) Right Ventricular Assist Devices (RVAD) Biventricular Assist Devices (BiVAD) Others |
| By End-User | Hospitals Cardiac Centers Home Care Settings Others |
| By Patient Type | Adult Patients Pediatric Patients Others |
| By Distribution Channel | Direct Sales Distributors Online Sales Others |
| By Region | Northern Vietnam Southern Vietnam Central Vietnam |
| By Technology | Pulsatile Flow Devices Continuous Flow Devices Others |
| By Application | Bridge to Transplantation Destination Therapy Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Cardiology Departments in Hospitals | 100 | Cardiologists, Cardiac Surgeons |
| Medical Device Distributors | 80 | Sales Managers, Product Specialists |
| Healthcare Procurement Officers | 70 | Procurement Managers, Supply Chain Directors |
| Patient Advocacy Groups | 50 | Patient Representatives, Healthcare Advocates |
| Regulatory Bodies | 30 | Regulatory Affairs Specialists, Compliance Officers |
The Vietnam Ventricular Assist Devices Market is valued at approximately USD 1.7 billion, reflecting a significant growth driven by increasing healthcare expenditure and the rising prevalence of cardiovascular diseases.